These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 3933340)

  • 1. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis.
    Di Minno G; Martinez J; McKean ML; De La Rosa J; Burke JF; Murphy S
    Am J Med; 1985 Nov; 79(5):552-9. PubMed ID: 3933340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 4. Stored human platelets retain full aggregation potential in response to pairs of aggregating agents.
    DiMinno G; Silver MJ; Murphy S
    Blood; 1982 Mar; 59(3):563-8. PubMed ID: 6800418
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of anti-platelet aggregating action of dilazep.
    Takenaga M; Kitagawa H; Hirai A; Tamura Y; Yoshida S
    J Pharmacobiodyn; 1985 Feb; 8(2):77-83. PubMed ID: 3925115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet secretion defect associated with impaired liberation of arachidonic acid and normal myosin light chain phosphorylation.
    Rao AK; Koike K; Willis J; Daniel JL; Beckett C; Hassel B; Day HJ; Smith JB; Holmsen H
    Blood; 1984 Oct; 64(4):914-21. PubMed ID: 6089937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
    Stuart MJ; Dusse J; Clark DA; Walenga RW
    Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis.
    Bloom A; Greaves M; Preston FE; Brown CB
    Br J Haematol; 1986 Jan; 62(1):143-9. PubMed ID: 3080018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.
    Remuzzi G; Benigni A; Dodesini P; Schieppati A; Livio M; De Gaetano G; Day SS; Smith WL; Pinca E; Patrignani P; Patrono C
    J Clin Invest; 1983 Mar; 71(3):762-8. PubMed ID: 6298281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet thromboxane synthesis and release reactions in myeloproliferative disorders.
    Smith IL; Martin TJ
    Haemostasis; 1982; 11(2):119-27. PubMed ID: 6211399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring the entry of new platelets into the circulation after ingestion of aspirin.
    Di Minno G; Silver MJ; Murphy S
    Blood; 1983 Jun; 61(6):1081-5. PubMed ID: 6404326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
    Carter AJ; Heptinstall S
    Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelation of platelet aggregation, release reaction and thromboxane A2 production.
    Balduini CL; Bertolino G; Noris P; Sinigaglia F; Bisio A; Torti M
    Biochem Biophys Res Commun; 1988 Oct; 156(2):823-9. PubMed ID: 3190682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A defect of platelet release reaction in a patient with SLE: impaired platelet aggregation induced by phorbol ester with a normal phosphorylation of 40K protein.
    Fuse I; Hattori A; Higashihara M; Takizawa S; Takeshige T; Hanano M; Nagayama R; Koike T; Takahashi H; Shibata A
    Scand J Haematol; 1986 Jan; 36(1):44-54. PubMed ID: 3081995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
    Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
    Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet function abnormalities in response to arachidonic acid in the acute phase of myocardial infarction.
    McDaniel HG; Maddox WT; Poon MC; Rogers WJ; Rackley CE
    Am J Cardiol; 1983 Nov; 52(8):965-8. PubMed ID: 6416046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of epinephrine on the aggregation response of aspirin-treated platelets.
    Rao GH; Johnson GJ; White JG
    Prostaglandins Med; 1980 Jul; 5(1):45-58. PubMed ID: 7403340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
    Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
    Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.